/entrackr/media/media_files/2025/08/13/dozee-2025-08-13-17-16-51.png)
Healthtech startup Dozee is set to raise $10 million (Rs 86 crore) in debt funding from Stockhausen International Pte Ltd, its second debt infusion in four months after a $7 million investment in March this year.
The board at Dozee passed a resolution to offer 7,545 Series B optionally convertible debentures at a face value of Rs 1,14,074 each to raise the aforementioned amount, according to its regulatory filing with the Registrar of Companies (RoC).
The proceeds from this funding will be used for business operations, development, and lending to subsidiaries outside India, the filing added.
Founded in 2015, Dozee provides remote health monitoring solutions through devices that track heart health, respiration, sleep quality, and stress levels. Dozee’s offerings include Shravan, an AI-powered device for early hearing screening and rehabilitation, and smart mat, a contactless device placed under a mattress to monitor vital signs like heart rate, respiration, stress, and sleep patterns.
Dozee is one of the fastest-growing players in Remote Patient Monitoring (RPM) and Early Warning Systems (EWS), and has recently earned the CE Mark under the EU MDR 2017/745, a global benchmark for medical device safety and efficacy.
According to startup data intelligence platform TheKredible, the Prime Venture Partners-backed company has raised around $38 million to date, including debt, from investors such as Yournest, 3One4 Capital, and Prime Venture Partners.
While the firm is yet to report FY25’s numbers, it reported Rs 5 crore in operating revenue for FY24. The Bengaluru-based company narrowed losses by nearly 20% to Rs 68 crore from Rs 84.4 crore in FY23.